Results 111 to 120 of about 2,003,708 (339)

The Treatment of Metastatic, Hormone-Sensitive Prostatic Carcinoma. [PDF]

Dtsch Arztebl Int, 2022
Merseburger AS, Krabbe LM, Krause BJ, Böhmer D, Perner S, Amsberg GV.   +5 more
europepmc   +1 more source

Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia [PDF]

, 1981
Jüngst, Dieter, Karl, Hans Josef, Lazik, E., Tauber, R.   +3 more
core   +1 more source

Bioorthogonal Fluorogenic Reporters for Noninvasive Imaging and Urinalysis of Immunotherapeutic Response in Renal Cell Carcinoma

Advanced Science, EarlyView.
This study reported renal‐clearable bio‐orthogonal near‐infrared fluorogenic probes (BGRs) that specifically imaging and urinalysis of granzyme B for dynamic evaluation of RCC immunotherapy. BGRs not only differentiate immunotherapeutic responses in orthotopic RCC mice, but also enable sensitive optical urinalysis of granzyme B in clinical specimens ...
Xingyue Yang, Baoshuai Liang, Liangmin Fu, Weiliang Deng, Yuyan Jiang, Weiping Xu, Jinwei Chen, Ya Zhou, Ke Wu, Jiaguo Huang   +9 more
wiley   +1 more source

Imaging of Neuroendocrine Prostatic Carcinoma. [PDF]

Cancers (Basel), 2021
Taher A, Jensen CT, Yedururi S, Surasi DS, Faria SC, Bathala TK, Mujtaba B, Bhosale P, Wagner-Bartak N, Morani AC.   +9 more
europepmc   +1 more source

Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities

Advanced Science, EarlyView.
ABSTRACT Despite the transformative impact of cancer immunotherapies such as immune checkpoint blockade, durable clinical responses remain limited. Increasing evidence indicates that antitumor immunity is governed not only by the tumor microenvironment, but also by systemic immune regulation mediated by peripheral immune organs. Among these, the spleen
Yuehua Liu, Xiaoqian Nie, Xiaofei Gao
wiley   +1 more source

Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series. [PDF]

Histopathology, 2022
Gopalan A, Al-Ahmadie H, Chen YB, Sarungbam J, Sirintrapun SJ, Tickoo SK, Reuter VE, Fine SW.   +7 more
europepmc   +1 more source

ROS‐Responsive Nanobubbles for Dual‐Enhanced Ultrasound and Magnetic Resonance Imaging of Tumor Oxidative Stress

Advanced Science, EarlyView.
We report the development of biotinylated PEGylated bilirubin‐coated perfluoropentane (bt‐PEG‐BR@PFP) nanobubbles, a novel class of ROS‐activatable and dual‐modality contrast agents that amplify both ultrasound (US) and magnetic resonance imaging (MRI) signals in response to elevated ROS.
Wonsik Jung, Youngju Son, Dong Yun Lee, Youngeun Jeon, Muhammad Asaddudin, Sung‐Hong Park, Sangyong Jon   +6 more
wiley   +1 more source

Dural metastases from prostatic cancer or chronic subdural hematoma

Revista Ciencias Biomédicas, 2012
Introduction: dural metastases of prostatic adenocarcinoma appear in advanced stagesof the disease and they can be the first manifestation of a prostatic carcinoma, evenwithout urological symptoms.Clinical case: a 71 year-old patient without previous ...
Taboada-Lora Luis Roberto, Bernal-Bernal David Alejandro, Navarro-Tovar Saúl   +2 more
doaj  

⁶⁸Ga-PSMA PET-CT and PSMA score affecting therapeutic decision-making in high-risk prostatic carcinoma. [PDF]

Pol J Radiol, 2023
Yasmin T, Younis MN, Ameer K, Farooq A, Shahid A.   +4 more
europepmc   +1 more source

Total prostatectomy as a treatment for prostatic carcinoma in 25 dogs

Veterinary surgery, 2018
Tristram Bennett, Brad M Matz, R. Henderson, R. Straw, J. Liptak, L. Selmic, F. Collivignarelli, P. Buracco   +7 more
semanticscholar   +1 more source